• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苯丙酮尿症患者生长发育受损与饮食治疗的严格程度相关吗?荷兰全国苯丙酮尿症指导委员会。

Does impaired growth of PKU patients correlate with the strictness of dietary treatment? National Dutch PKU Steering Committee.

作者信息

van Spronsen F J, Verkerk P H, van Houten M, Smit G P, van der Meer S B, Bakker H D, Sengers R C

机构信息

Beatrix Children's Hospital, University of Groningen, The Netherlands.

出版信息

Acta Paediatr. 1997 Aug;86(8):816-8. doi: 10.1111/j.1651-2227.1997.tb08603.x.

DOI:10.1111/j.1651-2227.1997.tb08603.x
PMID:9307159
Abstract

To assess whether growth retardation in patients with phenylketonuria (PKU) is related to the strictness of their dietary treatment, the relationship between Z scores for height up to 3 y of age and different indices of dietary control in 103 early treated Dutch PKU patients was studied. As indices of dietary control, the mean phenylalanine (Phe) concentration, the frequency of plasma Phe concentrations < 200 and < 120 micromol/l, and the standard deviation of the individual plasma Phe concentrations were studied. These measures of the dietary control were divided into quartiles. The mean Z score of the studied patients showed a decrease of 0.18/y (SD 0.36). No statistically significant difference between any of the quartiles of the studied indices with growth retardation was found. None of the used indices of dietary control based on plasma Phe concentrations showed a relationship between different degrees of the strictness of dietary treatment with growth retardation in Dutch PKU patients.

摘要

为评估苯丙酮尿症(PKU)患者的生长发育迟缓是否与其饮食治疗的严格程度相关,研究了103例早期接受治疗的荷兰PKU患者3岁前身高的Z评分与不同饮食控制指标之间的关系。作为饮食控制指标,研究了苯丙氨酸(Phe)平均浓度、血浆Phe浓度<200和<120微摩尔/升的频率以及个体血浆Phe浓度的标准差。这些饮食控制指标被分为四分位数。研究患者的平均Z评分显示每年下降0.18(标准差0.36)。在所研究指标的任何四分位数与生长发育迟缓之间未发现统计学上的显著差异。基于血浆Phe浓度的所有饮食控制指标均未显示荷兰PKU患者不同程度的饮食治疗严格程度与生长发育迟缓之间存在关联。

相似文献

1
Does impaired growth of PKU patients correlate with the strictness of dietary treatment? National Dutch PKU Steering Committee.苯丙酮尿症患者生长发育受损与饮食治疗的严格程度相关吗?荷兰全国苯丙酮尿症指导委员会。
Acta Paediatr. 1997 Aug;86(8):816-8. doi: 10.1111/j.1651-2227.1997.tb08603.x.
2
The relationship between dietary intake, growth and body composition in Phenylketonuria.苯丙酮尿症患者的饮食摄入、生长和身体成分之间的关系。
Mol Genet Metab. 2017 Sep;122(1-2):36-42. doi: 10.1016/j.ymgme.2017.07.007. Epub 2017 Jul 20.
3
Relationships between lumbar bone mineral density and biochemical parameters in phenylketonuria patients.苯丙酮尿症患者腰椎骨密度与生化参数的关系。
Mol Genet Metab. 2012 Apr;105(4):566-70. doi: 10.1016/j.ymgme.2012.01.006. Epub 2012 Jan 16.
4
Evaluation of nutritional status and pathophysiology of growth retardation in patients with phenylketonuria.苯丙酮尿症患者营养状况评估及生长发育迟缓的病理生理学研究
J Inherit Metab Dis. 2003;26(1):1-11. doi: 10.1023/a:1024063726046.
5
Early dietary treated patients with phenylketonuria can achieve normal growth and body composition.早期饮食治疗的苯丙酮尿症患者可以实现正常的生长和身体成分。
Mol Genet Metab. 2013;110 Suppl:S40-3. doi: 10.1016/j.ymgme.2013.10.009. Epub 2013 Oct 22.
6
A new, low-volume protein substitute for teenagers and adults with phenylketonuria.一种针对青少年和成年苯丙酮尿症患者的新型小剂量蛋白质替代品。
J Inherit Metab Dis. 2004;27(2):127-35. doi: 10.1023/B:BOLI.0000028784.11080.9b.
7
Predictors of mean phenylalanine levels during the first five years of life in patients with phenylketonuria who were treated early. Dutch National PKU Steering Committee.早期接受治疗的苯丙酮尿症患者生命最初五年期间平均苯丙氨酸水平的预测因素。荷兰国家苯丙酮尿症指导委员会。
Acta Paediatr Suppl. 1994 Dec;407:70-2. doi: 10.1111/j.1651-2227.1994.tb13456.x.
8
Impaired prenatal and postnatal growth in Dutch patients with phenylketonuria. The National PKU Steering Committee.荷兰苯丙酮尿症患者产前和产后生长发育受损。国家苯丙酮尿症指导委员会。
Arch Dis Child. 1994 Aug;71(2):114-8. doi: 10.1136/adc.71.2.114.
9
"MY PKU": increasing self-management in patients with phenylketonuria. A randomized controlled trial.“我的苯丙酮尿症”:提高苯丙酮尿症患者的自我管理能力。一项随机对照试验。
Orphanet J Rare Dis. 2011 Jun 27;6:48. doi: 10.1186/1750-1172-6-48.
10
Insurance Reimbursement for Special Foods and Phenylalanine Levels in Patients With PKU in China.中国苯丙酮尿症患者特殊食品和苯丙氨酸水平的保险报销
JAMA Netw Open. 2024 Jun 3;7(6):e2412886. doi: 10.1001/jamanetworkopen.2024.12886.

引用本文的文献

1
Multicenter study on long-term growth in patients with phenylketonuria.苯丙酮尿症患者长期生长情况的多中心研究。
Orphanet J Rare Dis. 2025 Aug 4;20(1):400. doi: 10.1186/s13023-025-03946-3.
2
Evaluating Therapy and Growth in Children with Phenylketonuria: A Retrospective Longitudinal Study from Two Romanian Centers.评估苯丙酮尿症患儿的治疗和生长情况:来自罗马尼亚两个中心的回顾性纵向研究。
Medicina (Kaunas). 2024 Jul 22;60(7):1185. doi: 10.3390/medicina60071185.
3
Dietary intake and nutritional status of patients with phenylketonuria in Taiwan.
台湾苯丙酮尿症患者的饮食摄入和营养状况。
Sci Rep. 2020 Sep 3;10(1):14537. doi: 10.1038/s41598-020-71361-8.
4
Long-Term Growth in Phenylketonuria: A Systematic Review and Meta-Analysis.苯丙酮尿症的长期生长:系统评价和荟萃分析。
Nutrients. 2019 Sep 3;11(9):2070. doi: 10.3390/nu11092070.
5
Growth, Protein and Energy Intake in Children with PKU Taking a Weaning Protein Substitute in the First Two Years of Life: A Case-Control Study.在生命的头两年中使用断奶蛋白质替代品的苯丙酮尿症儿童的生长、蛋白质和能量摄入:病例对照研究。
Nutrients. 2019 Mar 5;11(3):552. doi: 10.3390/nu11030552.
6
The complete European guidelines on phenylketonuria: diagnosis and treatment.《苯丙酮尿症的完整欧洲指南:诊断与治疗》。
Orphanet J Rare Dis. 2017 Oct 12;12(1):162. doi: 10.1186/s13023-017-0685-2.
7
Phenylketonuria: dietary and therapeutic challenges.苯丙酮尿症:饮食与治疗挑战
J Inherit Metab Dis. 2007 Apr;30(2):145-52. doi: 10.1007/s10545-007-0552-8. Epub 2007 Mar 8.
8
The intake of total protein, natural protein and protein substitute and growth of height and head circumference in Dutch infants with phenylketonuria.荷兰苯丙酮尿症婴儿的总蛋白、天然蛋白和蛋白质替代品摄入量以及身高和头围的增长情况
J Inherit Metab Dis. 2005;28(6):845-54. doi: 10.1007/s10545-005-0122-x.
9
Evaluation of nutritional status and pathophysiology of growth retardation in patients with phenylketonuria.苯丙酮尿症患者营养状况评估及生长发育迟缓的病理生理学研究
J Inherit Metab Dis. 2003;26(1):1-11. doi: 10.1023/a:1024063726046.
10
Elevated plasma phenylalanine concentrations may adversely affect bone status of phenylketonuric mice.
J Inherit Metab Dis. 2002 Sep;25(5):347-61. doi: 10.1023/a:1020191515173.